Figure 2From: Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alonePlasma C-peptide concentrations during OGTTs performed in patients with DM-NAFLD and those with T2DM only. Plasma C-peptide concentrations at 0, 30, 60, 120, and 180 min after the OGTT was administered.Back to article page